human apoptosis array kit Search Results


proteome profiler apoptotic array kit  (R&D Systems)
96
R&D Systems proteome profiler apoptotic array kit
A. Oral cancer cell line H357 sensitive and H357cisR was seeded on 6 well plates and treated with different concentrations 5, 10, and 15 ug mL-1. With respect to time, the cell morphology changes and becomes rounded in shape, and at higher concentration cell starts to detach from the surface. B. H357CisR cells were treated with indicated dose of TDEF for 48 hrs after which cell death was determined by annexin V/7AAD assay using flow cytometer. The dot plots represent the percentage of early <t>apoptotic</t> (lower right) and late apoptotic cells (upper right). C. Bar diagrams indicate the percentage of cell death; black color portion indicates percentage of early apoptosis and grey color indicates percentage of late apoptosis occur with respective treated groups. D. TDEF treated H357cisR cell pellet was fixed with 70% ethanol and stained with propidium iodide and the cell distribution in different cell cycle phases was analyzed by FACS. Cell cycle arrest was shown highest at 10 ug mL-1 but the cell with the higher concentration of extract has experience apoptosis and necrosis. The percentage of the G1 population was found to be 65.1%, and the control G1 cell population was 47.8%.
Proteome Profiler Apoptotic Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+apoptosis+array+kit/pmc10998759-175-11-17?v=R%26D+Systems
Average 96 stars, based on 1 article reviews
proteome profiler apoptotic array kit - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
proteome profiler human apoptosis array kit  (R&D Systems)
96
R&D Systems proteome profiler human apoptosis array kit
A. Oral cancer cell line H357 sensitive and H357cisR was seeded on 6 well plates and treated with different concentrations 5, 10, and 15 ug mL-1. With respect to time, the cell morphology changes and becomes rounded in shape, and at higher concentration cell starts to detach from the surface. B. H357CisR cells were treated with indicated dose of TDEF for 48 hrs after which cell death was determined by annexin V/7AAD assay using flow cytometer. The dot plots represent the percentage of early <t>apoptotic</t> (lower right) and late apoptotic cells (upper right). C. Bar diagrams indicate the percentage of cell death; black color portion indicates percentage of early apoptosis and grey color indicates percentage of late apoptosis occur with respective treated groups. D. TDEF treated H357cisR cell pellet was fixed with 70% ethanol and stained with propidium iodide and the cell distribution in different cell cycle phases was analyzed by FACS. Cell cycle arrest was shown highest at 10 ug mL-1 but the cell with the higher concentration of extract has experience apoptosis and necrosis. The percentage of the G1 population was found to be 65.1%, and the control G1 cell population was 47.8%.
Proteome Profiler Human Apoptosis Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+apoptosis+array+kit/pm34103685-293-1-7?v=R%26D+Systems
Average 96 stars, based on 1 article reviews
proteome profiler human apoptosis array kit - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
human apoptosis proteome profiler  (RayBiotech inc)
90
RayBiotech inc human apoptosis proteome profiler
A. Oral cancer cell line H357 sensitive and H357cisR was seeded on 6 well plates and treated with different concentrations 5, 10, and 15 ug mL-1. With respect to time, the cell morphology changes and becomes rounded in shape, and at higher concentration cell starts to detach from the surface. B. H357CisR cells were treated with indicated dose of TDEF for 48 hrs after which cell death was determined by annexin V/7AAD assay using flow cytometer. The dot plots represent the percentage of early <t>apoptotic</t> (lower right) and late apoptotic cells (upper right). C. Bar diagrams indicate the percentage of cell death; black color portion indicates percentage of early apoptosis and grey color indicates percentage of late apoptosis occur with respective treated groups. D. TDEF treated H357cisR cell pellet was fixed with 70% ethanol and stained with propidium iodide and the cell distribution in different cell cycle phases was analyzed by FACS. Cell cycle arrest was shown highest at 10 ug mL-1 but the cell with the higher concentration of extract has experience apoptosis and necrosis. The percentage of the G1 population was found to be 65.1%, and the control G1 cell population was 47.8%.
Human Apoptosis Proteome Profiler, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+apoptosis+array+kit/pm30551416-75-0-4?v=RayBiotech+inc
Average 90 stars, based on 1 article reviews
human apoptosis proteome profiler - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
apoptosis antibody array  (RayBiotech inc)
90
RayBiotech inc apoptosis antibody array
Results of <t>apoptosis</t> antibody array data. (A) Heat maps of differentially expressed proteins between K562 and K562/G cells, the cut-off value was set as follows: Fold-change <1.2 or <0.83, fluorescent value >150 and P<0.05 (K562/G VS K562). (B) Kyoto Encyclopedia of Genes and Genomes pathway analysis of differentially expressed proteins.
Apoptosis Antibody Array, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+apoptosis+array+kit/pmc07027099-68-1-4?v=RayBiotech+inc
Average 90 stars, based on 1 article reviews
apoptosis antibody array - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
human apoptosis cytometric bead array kit  (Becton Dickinson)
90
Becton Dickinson human apoptosis cytometric bead array kit
Results of <t>apoptosis</t> antibody array data. (A) Heat maps of differentially expressed proteins between K562 and K562/G cells, the cut-off value was set as follows: Fold-change <1.2 or <0.83, fluorescent value >150 and P<0.05 (K562/G VS K562). (B) Kyoto Encyclopedia of Genes and Genomes pathway analysis of differentially expressed proteins.
Human Apoptosis Cytometric Bead Array Kit, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+apoptosis+array+kit/10__1158_slash_1535___7163__mct___10___0205-51-14-20?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
human apoptosis cytometric bead array kit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
human apoptosis array kit ary 009  (Promega)
90
Promega human apoptosis array kit ary 009
PAI1 rs7242 is involved in the resistance to <t>apoptosis</t> induced by cisplatin. ( A ) Protein and mRNA expression of PAI1 clones in stable transfectants in UROtsa and 5637 cell lines. ( B ) Apoptosis assays using RealTime-Glo™ Annexin V Apoptosis and Caspase-Glo ® 3/7 Assays. ( C ) Profiling the expression of multiple proteins associated with apoptosis induced by cisplatin using a membrane-based sandwich immunoassay. ( D ) mRNA expression levels of ATR-CLSPN-CHEK1 pathway. ( E ) Silencing CLSPN by siRNA in parental UROtsa and 5637 cell lines. ( F ) Cell survival assay after cisplatin treatment. ( G ) Apoptosis assay after cisplatin treatment. Bars represent SE. ** p < 0.01; *** p < 0.001, **** p < 0. 0001.
Human Apoptosis Array Kit Ary 009, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+apoptosis+array+kit/pmc10003630-194-11-17?v=Promega
Average 90 stars, based on 1 article reviews
human apoptosis array kit ary 009 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
human apoptosis array kit/proteome profiler  (SMAC Corp)
90
SMAC Corp human apoptosis array kit/proteome profiler
PAI1 rs7242 is involved in the resistance to <t>apoptosis</t> induced by cisplatin. ( A ) Protein and mRNA expression of PAI1 clones in stable transfectants in UROtsa and 5637 cell lines. ( B ) Apoptosis assays using RealTime-Glo™ Annexin V Apoptosis and Caspase-Glo ® 3/7 Assays. ( C ) Profiling the expression of multiple proteins associated with apoptosis induced by cisplatin using a membrane-based sandwich immunoassay. ( D ) mRNA expression levels of ATR-CLSPN-CHEK1 pathway. ( E ) Silencing CLSPN by siRNA in parental UROtsa and 5637 cell lines. ( F ) Cell survival assay after cisplatin treatment. ( G ) Apoptosis assay after cisplatin treatment. Bars represent SE. ** p < 0.01; *** p < 0.001, **** p < 0. 0001.
Human Apoptosis Array Kit/Proteome Profiler, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+apoptosis+array+kit/pm21403465-58-104-95?v=SMAC+Corp
Average 90 stars, based on 1 article reviews
human apoptosis array kit/proteome profiler - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


A. Oral cancer cell line H357 sensitive and H357cisR was seeded on 6 well plates and treated with different concentrations 5, 10, and 15 ug mL-1. With respect to time, the cell morphology changes and becomes rounded in shape, and at higher concentration cell starts to detach from the surface. B. H357CisR cells were treated with indicated dose of TDEF for 48 hrs after which cell death was determined by annexin V/7AAD assay using flow cytometer. The dot plots represent the percentage of early apoptotic (lower right) and late apoptotic cells (upper right). C. Bar diagrams indicate the percentage of cell death; black color portion indicates percentage of early apoptosis and grey color indicates percentage of late apoptosis occur with respective treated groups. D. TDEF treated H357cisR cell pellet was fixed with 70% ethanol and stained with propidium iodide and the cell distribution in different cell cycle phases was analyzed by FACS. Cell cycle arrest was shown highest at 10 ug mL-1 but the cell with the higher concentration of extract has experience apoptosis and necrosis. The percentage of the G1 population was found to be 65.1%, and the control G1 cell population was 47.8%.

Journal: American Journal of Cancer Research

Article Title: Tolypothrix Dichloromethane Ethylacetate fraction (TDEF) inhibits cisplatin resistance H357 cell through PI3K/AKT/beta-catenin pathway

doi: 10.62347/JTNQ4812

Figure Lengend Snippet: A. Oral cancer cell line H357 sensitive and H357cisR was seeded on 6 well plates and treated with different concentrations 5, 10, and 15 ug mL-1. With respect to time, the cell morphology changes and becomes rounded in shape, and at higher concentration cell starts to detach from the surface. B. H357CisR cells were treated with indicated dose of TDEF for 48 hrs after which cell death was determined by annexin V/7AAD assay using flow cytometer. The dot plots represent the percentage of early apoptotic (lower right) and late apoptotic cells (upper right). C. Bar diagrams indicate the percentage of cell death; black color portion indicates percentage of early apoptosis and grey color indicates percentage of late apoptosis occur with respective treated groups. D. TDEF treated H357cisR cell pellet was fixed with 70% ethanol and stained with propidium iodide and the cell distribution in different cell cycle phases was analyzed by FACS. Cell cycle arrest was shown highest at 10 ug mL-1 but the cell with the higher concentration of extract has experience apoptosis and necrosis. The percentage of the G1 population was found to be 65.1%, and the control G1 cell population was 47.8%.

Article Snippet: Protein array analysis Human apoptosis array analysis was performed using a proteome profiler apoptotic array kit (ARY009; R & D system.

Techniques: Concentration Assay, Flow Cytometry, Staining, Control

A. The Pp53 and P21 signalling pathways are strongly activated by TDEF treatment. The human apoptosis proteome profiler array used a protein extract (400 µg). The intensities of each array spot were visualized and further quantified using an image. B. The graph shows the relative fold change of proteins with significant differences upon TDEF treatment, setting 1 for control (no treatment of TDEF). Protein levels with higher than ± 2 folds are considered candidates for TDEF-induced cell death.

Journal: American Journal of Cancer Research

Article Title: Tolypothrix Dichloromethane Ethylacetate fraction (TDEF) inhibits cisplatin resistance H357 cell through PI3K/AKT/beta-catenin pathway

doi: 10.62347/JTNQ4812

Figure Lengend Snippet: A. The Pp53 and P21 signalling pathways are strongly activated by TDEF treatment. The human apoptosis proteome profiler array used a protein extract (400 µg). The intensities of each array spot were visualized and further quantified using an image. B. The graph shows the relative fold change of proteins with significant differences upon TDEF treatment, setting 1 for control (no treatment of TDEF). Protein levels with higher than ± 2 folds are considered candidates for TDEF-induced cell death.

Article Snippet: Protein array analysis Human apoptosis array analysis was performed using a proteome profiler apoptotic array kit (ARY009; R & D system.

Techniques: Control

Results of apoptosis antibody array data. (A) Heat maps of differentially expressed proteins between K562 and K562/G cells, the cut-off value was set as follows: Fold-change <1.2 or <0.83, fluorescent value >150 and P<0.05 (K562/G VS K562). (B) Kyoto Encyclopedia of Genes and Genomes pathway analysis of differentially expressed proteins.

Journal: Experimental and Therapeutic Medicine

Article Title: Insulin-like growth factor-binding proteins play a significant role in the molecular response to imatinib in chronic myeloid leukemia patients

doi: 10.3892/etm.2019.8364

Figure Lengend Snippet: Results of apoptosis antibody array data. (A) Heat maps of differentially expressed proteins between K562 and K562/G cells, the cut-off value was set as follows: Fold-change <1.2 or <0.83, fluorescent value >150 and P<0.05 (K562/G VS K562). (B) Kyoto Encyclopedia of Genes and Genomes pathway analysis of differentially expressed proteins.

Article Snippet: An apoptosis antibody array (Ray Biotech, Inc.) was used to explore the differences in the apoptotic protein profile between K562 and K562/G cells.

Techniques: Ab Array

PAI1 rs7242 is involved in the resistance to apoptosis induced by cisplatin. ( A ) Protein and mRNA expression of PAI1 clones in stable transfectants in UROtsa and 5637 cell lines. ( B ) Apoptosis assays using RealTime-Glo™ Annexin V Apoptosis and Caspase-Glo ® 3/7 Assays. ( C ) Profiling the expression of multiple proteins associated with apoptosis induced by cisplatin using a membrane-based sandwich immunoassay. ( D ) mRNA expression levels of ATR-CLSPN-CHEK1 pathway. ( E ) Silencing CLSPN by siRNA in parental UROtsa and 5637 cell lines. ( F ) Cell survival assay after cisplatin treatment. ( G ) Apoptosis assay after cisplatin treatment. Bars represent SE. ** p < 0.01; *** p < 0.001, **** p < 0. 0001.

Journal: International Journal of Molecular Sciences

Article Title: Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer

doi: 10.3390/ijms24054943

Figure Lengend Snippet: PAI1 rs7242 is involved in the resistance to apoptosis induced by cisplatin. ( A ) Protein and mRNA expression of PAI1 clones in stable transfectants in UROtsa and 5637 cell lines. ( B ) Apoptosis assays using RealTime-Glo™ Annexin V Apoptosis and Caspase-Glo ® 3/7 Assays. ( C ) Profiling the expression of multiple proteins associated with apoptosis induced by cisplatin using a membrane-based sandwich immunoassay. ( D ) mRNA expression levels of ATR-CLSPN-CHEK1 pathway. ( E ) Silencing CLSPN by siRNA in parental UROtsa and 5637 cell lines. ( F ) Cell survival assay after cisplatin treatment. ( G ) Apoptosis assay after cisplatin treatment. Bars represent SE. ** p < 0.01; *** p < 0.001, **** p < 0. 0001.

Article Snippet: To investigate how PAI1 might inhibit apoptosis, we used an array (Human Apoptosis Array Kit; ARY 009, Promega, Madison, WI, USA) which monitors 35 apoptosis-related proteins.

Techniques: Expressing, Clone Assay, Membrane, Clonogenic Cell Survival Assay, Apoptosis Assay